Marcus Torr provides about his perspective about the importance of PMCF Survey implementation for medical device EU-MDR submissions. He reveals why medical device manufacturers should consider PMCF surveys, how to overcome challenges, solutions for a best practice approach and what makes Purdie Pascoe’s specialist expertise unique.

Purdie Pascoe Post Market Clinical Follow-up (PMCF) Survey experts, Marcus Torr and Chris Webb recently attended the RAPS European Clinical, Risk and Postmarket Surveillance Conference in Barcelona, Spain.

Whether you're new to PMCF or looking to refine your approach, this webcast is designed to provide actionable insights to help you achieve success in your PMCF activities, stay ahead of the curve and ensure your medical devices meet the highest standards of safety and performance.

The Purdie Pascoe Post Market Clinical Follow-up (PMCF) team was out in full force at this this year’s Regulatory Affairs Professionals Society (RAPS) conference in Long Beach, California in September.

PMCF is an essential aspect of medical device regulation. In this interview Marcus Torr provides a breakdown of the best approach, including how it can improve patient safety as well as the challenges it poses for small to medium-sized enterprises.

Post-market clinical follow-up (PMCF) surveys have become a significant topic in the industry, offering a cost-effective solution for PMCF data collection. However, their effective implementation can be challenging. In this article, the PMCF experts at Purdie Pascoe focus on high-quality, case/patient-specific PMCF surveys that provide Level 4 data.

Watch this webcast with experts from Purdie Pascoe and Global RWC. Watch the webcast to gain key learnings such as proper survey planning , best practices for PMCF survey design  and what to do with your PMCF data.

The EU Medical Device Regulation (EU MDR) is a new and updated set of regulations, following on from the Medical Device Directive (MDD), that will now come into force on May 26, 2021.